Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
CAV3.2 antibody
| Antigen | CAV3.2 |
| Clonality | Monoclonal (S55-10) |
| Host |
Mouse |
| Reactivity |
Human, Mouse (Murine), Rat (Rattus) |
| Application |
Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)
|
![]() |
3 references available |
| Catalog no. | ABIN361762 |
| Quantity | 100µg (1 mg/mL) |
| Price | 325.00 $ Plus shipping costs $35.00 |
| Shipping to |
|
| Availability | Ships within 7 to 10 Business Days |
Additional Information
| Characteristics | Detects ~260kDa. No cross-reactivity against Cav1.3 |
| Gene ID | 8912 |
| Swiss-Prot | O95180 |
| Immunogen | Fusion protein amino acids 1019-1293 (II-III loop) of human Cav3.2, accession number O95180 |
| Format | Liquid |
| Isotype | IgG1 (Matching secondary antibodies) |
| Clone | S55-10 |
| Description |
Specifically, Cav3.2 is a protein which in humans is encoded by the CACNA1H gene. Studies suggest certain mutations in this gene lead to childhood absence epilepsy . Studies also suggest that the up-regulations of Cav3.2 may participate in the progression of prostate cancer toward an androgen-independent stage. Synonyms: CACNA1HB, Alpha1 3.2, CACNA 1H, CACNA1 HB, Cav T.2, EIG6, Voltage dependent T type calcium channel alpha 1H |
| Specificity | ~260kDa. No cross-reactivity against Cav1.3. Species cross-reactivity: Human. |
| Sensitivity | 1 µg/mL of SMC-303 was sufficient for detection of Cav3.2 in 10µg of HEK cell lysate expressing Cav3.2 by colorimetric immunoblot analysis using Goat anti-mouse IgG:HRP as the secondary antibody. |
Application Details
| Application Notes | 1-10ug/mL (WB), 0.1-1.0ug/mL (Perox) (IHC/ICC), 1.0-10ug/mL (IF) |
| Concentration | 1 mg/mL |
| Purification | Protein G Purified |
| Buffer | PBS pH7.4, 50% glycerol |
| Storage | -20 °C |
| Storage Shipping Temp Max | Blue Ice or 4 °C |
| Restrictions | For Research Use only |
Publications
| Publications |
Chen, Lu, Pan et al.: "Association between genetic variation of CACNA1H and childhood absence epilepsy." in: Annals of neurology, Vol. 54, Issue 2, pp. 239-43, 2003 (PubMed).
Khosravani, Altier, Simms et al.: "Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy." in: The Journal of biological chemistry, Vol. 279, Issue 11, pp. 9681-4, 2004 (PubMed). Gackiuere, Bidaux, Delcourt et al.: "CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells." in: The Journal of biological chemistry, Vol. 283, Issue 15, pp. 10162-73, 2008 (PubMed). |




